Skip to content

Movement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDD

Avaliação de Uma intervenção de promoção Atividade física em Pacientes Com depressão Maior em Atendimento Ambulatorial (MOVEDEP): um Ensaio clínico Randomizado

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03403881
Acronym
MOVEDEP
Enrollment
130
Registered
2018-01-19
Start date
2016-03-31
Completion date
2019-05-31
Last updated
2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

Exercise, Physical activity, Behavioral change, Depression, Major Depressive Disorder, Health promotion

Brief summary

Randomized clinical trial that aims to increase physical activity levels in people with depression and to evaluate if the increase on PA levels has impact on clinical and biological measures.

Detailed description

The contacts will be made by face-to-face interviews and telephone calls

Interventions

BEHAVIORALPhysical activity promotion + TAU

Pedometer: Each patient will receive a pedometer with increasing weekly aims on number of steps during the trial. The number of steps to be achieved starts on 4.000 and increases progressively until the end of the trial. Behavioral strategy based on STD theory, and the assessment of barriers and facilitators of each patient. All patients were receiving treatment as usual

BEHAVIORALControl

Weekly call on general health aspects + treatment as usual

Sponsors

Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age: 18 - 65 years; * diagnosis of Major Depressive Disorder (DSM-IV), assessed by a trained psychiatrist; * score 7 or more in the HAM-D; * do not present clinical comorbidities that limit or contra-indicate the practice of physical activity; * be starting depression treatment at the Programa de transtorno do humor (PROTHUM) ; * have acess to a computer and have a facebook account; * be able to read and sign the consent term.

Exclusion criteria

* present other psychiatric diagnosis such as bipolar disorder, schizophrenia or use of alcohol or other drugs; * be not liberated to the practice of physical exercises by the assistant psychiatrist.

Design outcomes

Primary

MeasureTime frameDescription
Depressive symptoms (blinded assessment)At the end of the intervention (6 months)Hamilton scale for depressive symptoms assessed by a blinded psychiatrist. Clinician-administered semi-structured interview with 17 questions. It is designed to measure the severity of depressive symptoms in patients with a primary depressive illness. Higher scores means higher depressive symptoms. The cutoffs are the following: following severity ranges for the HAMD: no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe depression (≥24). The maximum score is 52.

Secondary

MeasureTime frameDescription
Physical activity levels - objective measureAt the end of the intervention (6 months)pedometer (only for intervention group)
Quality of lifeAt the end of the intervention (6 months)WHOQOL-BREF
Physical activity - self-reportAt the end of the intervention (6 months)IPAQ
MelancholiaAt the end of the intervention (6 months)assessed using the CORE instrument
WeightAt the end of the intervention (6 months)Weight in kilograms
Depressive symptoms (self-reported)At the end of the intervention (6 months)Beck depressive inventory

Countries

Brazil

Contacts

Primary ContactPhD
Backup ContactFelipe Schuch, PhD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026